Sahana Eden is an Open Source Humanitarian Platform which can be used to provide solutions for Disaster Management, Development, and Environmental Management sectors.. Please sign CLA when submitti… ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

The downsizing is planned for May 12. — Cargo Therapeutics, 84 layoffs in San Carlos. The biotech company is halting development and is closing its San Carlos site. The downsizing is planned for ...

Alcon's acquisition of Aurion Biotech enhances its cell therapy capabilities for eye diseases, with Aurion operating independently under Alcon's support. Aurion's AURN001, an allogeneic cell therapy ...

Artificial intelligence (AI) has taken the biotech industry by storm, allowing companies to speed up the drug discovery process while also making it more cost-effective. With so many companies in the ...

The Kerala assembly Tuesday (March 25) passed a draft bill that will now allow entry to private universities in the state. The Kerala State Private Universities (Establishment and Regulation) Bill, ...

CINCINNATI (Cincinnati Business Courier) - A growing biotech and pharmaceuticals manufacturer that announced a large investment in Greater Cincinnati a little over a year ago has unveiled new ...

Merck MRK announced that it has entered into an exclusive licensing deal with China-based Jiangsu Hengrui Pharmaceuticals (Hengrui Pharma) for the latter’s investigational oral small-molecule ...

There remains much uncertainty about these measures, however. As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and negative news.

A New Jersey-based biotech is looking to become the main character in the age-related macular degeneration field. Character Biosciences has landed a $93 million series B to progress its precision ...

The biotech industry may be cooling off, but there’s still plenty to be excited about when it comes to the underlying innovations. Chances are, the next great medical breakthrough is already in ...